Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Insulet Corporation
Insulet Corporation Announces Private Offering of $65 Million of Convertible Senior Notes
June 29th, 2008
Insulet Corporation (the "Company") (NASDAQ:PODD) announced that it has commenced an offering of $65 million in aggregate principal amount of convertible senior notes due 2013 (the "notes") through an offering to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended. The Company expects to grant the initial purchasers an option to purchase up to an additional $10 million in aggregate principal amount of notes solely to cover over-allotments, if any. The notes will be convertible under certain circumstances into cash up to their principal amount and shares of the Company's common stock for the remainder, if any, of the...
Source: Pharma Investments, Ventures & Law Weekly (2008-06-29)
|
